Renee D. Gala - 17 Jan 2025 Form 4 Insider Report for Jazz Pharmaceuticals plc (JAZZ)

Signature
By: /s/Adam Guttmann, as attorney in fact For: Renee D Gala
Issuer symbol
JAZZ
Transactions as of
17 Jan 2025
Net transactions value
-$404,646
Form type
4
Filing time
22 Jan 2025, 18:50:45 UTC
Previous filing
09 Dec 2024
Next filing
03 Mar 2025

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction JAZZ Ordinary Shares Award $0 +7,741 +14% $0.000000 63,233 17 Jan 2025 Direct F1
transaction JAZZ Ordinary Shares Tax liability $404,646 -3,300 -5.2% $122.62 59,933 17 Jan 2025 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified.
F2 Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations.